Digital Health in Switzerland: Are We Still Missing the Mark?
After a symposium on AI in medicine at the CHUV, the author asks whether Swiss digital health funding, centred on research and publications, produces pilot projects that never scale, and proposes ways to favour real-world impact.
This article is more than a year old. Some of its findings may have changed since.
From impressive research to the epidemic of pilot projects that never scale
I recently attended the 1st Symposium on AI-Driven Advances in Clinical and Translational Medicine at the CHUV, and I left with mixed feelings. While the research presented (including mine) was undeniably impressive, I couldn't help but wonder: Are we truly solving the real pain points in Swiss healthcare?
The Swiss Investment Paradox
The Swiss Confederation has invested millions into digital health to bridge our 20+ year gap behind leading countries. Yet our funding models primarily support research projects led by brilliant minds whose careers revolve around grants and publications – not scalable practical solutions.
We've normalized spending millions on projects that end with impressive papers but minimal societal impact. Is this really the best we can do?
We're drowning in "pilotitis" – an epidemic of pilot projects that never reach meaningful implementation.
Look around and you'll only see grand events celebrating great achievements. But the reality? I see either complacency or frustration, and I demand more. We need deep systemic changes.
How to Break Free
Shift from publication-centric to impact-driven research
Let's rebalance our metrics: shifting to 80% real-world impact, 20% citations instead of the opposite isn't just possible – it's necessary.
Embrace "start small, scale fast"
Stop overthinking perfect solutions for years. Launch minimal viable products, iterate with users, and scale what works. In AI, validation before deployment only doesn't even make sense – both aspects must evolve together.
Transform researchers into solution architects
While we chase grand ideas and foundation models, we're missing opportunities to maximize societal impact. Let's learn from traditional engineering and teach young minds to create value. And yes, they might still publish in Nature or Science.
Abandon the Swiss quality syndrome
Stop assuming we lead and start looking for existing solutions. Many pioneers blazed this trail in the early 2000s, developing frameworks that prioritize real-world readiness.
What Success Requires
I believe we can balance groundbreaking research with impact-driven solutions. This will require:
- Shifted incentives - rewarding both exploration and implementation
- Real-world problem solving - understanding that solutions go beyond medical aspects and data standardization
- Democratic innovation - giving clinicians and patients a genuine voice in research projects
- Industry-proven practices - ensuring scalability from day one
The stakes? Nothing less than the future of healthcare in Switzerland. We must advance beyond perpetual pilots to scalable solutions!